120 related articles for article (PubMed ID: 20930565)
1. Dried influenza vaccines: over the counter vaccines.
Saluja V; Hinrichs WL; Frijlink HW
Hum Vaccin; 2010 Oct; 6(10):854-6. PubMed ID: 20930565
[TBL] [Abstract][Full Text] [Related]
2. Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.
Murugappan S; Patil HP; Kanojia G; ter Veer W; Meijerhof T; Frijlink HW; Huckriede A; Hinrichs WL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):716-25. PubMed ID: 23933147
[TBL] [Abstract][Full Text] [Related]
3. Developments in the formulation and delivery of spray dried vaccines.
Kanojia G; Have RT; Soema PC; Frijlink H; Amorij JP; Kersten G
Hum Vaccin Immunother; 2017 Oct; 13(10):2364-2378. PubMed ID: 28925794
[TBL] [Abstract][Full Text] [Related]
4. Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination.
Tomar J; Born PA; Frijlink HW; Hinrichs WL
Expert Rev Vaccines; 2016 Nov; 15(11):1431-1447. PubMed ID: 27118428
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying.
Lovalenti PM; Anderl J; Yee L; Nguyen V; Ghavami B; Ohtake S; Saxena A; Voss T; Truong-Le V
Pharm Res; 2016 May; 33(5):1144-60. PubMed ID: 26818839
[TBL] [Abstract][Full Text] [Related]
6. Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation.
Flood A; Estrada M; McAdams D; Ji Y; Chen D
PLoS One; 2016; 11(11):e0164692. PubMed ID: 27851765
[TBL] [Abstract][Full Text] [Related]
7. Stability of collapse lyophilized influenza vaccine formulations.
Anamur C; Winter G; Engert J
Int J Pharm; 2015 Apr; 483(1-2):131-41. PubMed ID: 25660049
[TBL] [Abstract][Full Text] [Related]
8. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation.
Maa YF; Ameri M; Shu C; Payne LG; Chen D
J Pharm Sci; 2004 Jul; 93(7):1912-23. PubMed ID: 15176078
[TBL] [Abstract][Full Text] [Related]
9. Development of stable influenza vaccine powder formulations: challenges and possibilities.
Amorij JP; Huckriede A; Wilschut J; Frijlink HW; Hinrichs WL
Pharm Res; 2008 Jun; 25(6):1256-73. PubMed ID: 18338241
[TBL] [Abstract][Full Text] [Related]
10. Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.
Patil HP; Murugappan S; de Vries-Idema J; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
Eur J Pharm Biopharm; 2015 Jun; 93():231-41. PubMed ID: 25896446
[TBL] [Abstract][Full Text] [Related]
11. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ
Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
[TBL] [Abstract][Full Text] [Related]
12. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.
Saluja V; Amorij JP; Kapteyn JC; de Boer AH; Frijlink HW; Hinrichs WL
J Control Release; 2010 Jun; 144(2):127-33. PubMed ID: 20219608
[TBL] [Abstract][Full Text] [Related]
13. Dry Formulations Enhanced Mucoadhesive Properties and Reduced Cold Chain Handing of Influenza Vaccines.
Saengkrit N; Saesoo S; Woramongkolchai N; Sajomsang W; Phunpee S; Dharakul T; Ruktanonchai UR
AAPS PharmSciTech; 2018 Nov; 19(8):3763-3769. PubMed ID: 30259401
[TBL] [Abstract][Full Text] [Related]
14. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
15. Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates.
Scherließ R; Ajmera A; Dennis M; Carroll MW; Altrichter J; Silman NJ; Scholz M; Kemter K; Marriott AC
Vaccine; 2014 Apr; 32(19):2231-40. PubMed ID: 24631078
[TBL] [Abstract][Full Text] [Related]
16. Spray-Dried Influenza Antigen with Trehalose and Leucine Produces an Aerosolizable Powder Vaccine Formulation that Induces Strong Systemic and Mucosal Immunity after Pulmonary Administration.
Sou T; Morton DA; Williamson M; Meeusen EN; Kaminskas LM; McIntosh MP
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):361-71. PubMed ID: 25714115
[TBL] [Abstract][Full Text] [Related]
17. A pilot study using a novel pyrotechnically driven prototype applicator for epidermal powder immunization in piglets.
Engert J; Anamur C; Engelke L; Fellner C; Lell P; Henke S; Stadler J; Zöls S; Ritzmann M; Winter G
Int J Pharm; 2018 Jul; 545(1-2):215-228. PubMed ID: 29684561
[TBL] [Abstract][Full Text] [Related]
18. Development of a thermostable microneedle patch for influenza vaccination.
Mistilis MJ; Bommarius AS; Prausnitz MR
J Pharm Sci; 2015 Feb; 104(2):740-9. PubMed ID: 25448542
[TBL] [Abstract][Full Text] [Related]
19. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.
Poland GA; Fleming DM; Treanor JJ; Maraskovsky E; Luke TC; Ball EM; Poland CM
Vaccine; 2013 Apr; 31 Suppl 1():A1-20. PubMed ID: 23587330
[TBL] [Abstract][Full Text] [Related]
20. Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine.
Durando P; Iudici R; Alicino C; Alberti M; de Florentis D; Ansaldi F; Icardi G
Hum Vaccin; 2011; 7 Suppl():29-40. PubMed ID: 21245655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
